Spine devicemaker earns additional FDA clearance for SI joint system

The FDA on Jan. 31 gave Alevio Spine additional 510(k) clearance for the devicemaker’s SI-Cure sacroiliac joint fusion system.

Advertisement

The added indications include sacroiliac fusion for skeletally mature patients undergoing sacropelvic fixation as part of a lumbar or lumbar or thoracolumbar spinal fusion, according to a news release. Clinical studies found the SI-Cure system can decrease the risk of disability and prevent the development of postoperative SI joint pain.

The device was previously cleared for SI fusion for sacroiliac joint dysfunction and fractures involving the sacroiliac joint.

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.